Generic name:omacetaxine [ OH-ma-se-TAX-een ]
Drug class:Miscellaneous antineoplastics
What is Synribo?
Synribo is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Synribo injection is used to treat chronic myeloid leukemia (CML).
Synribo is given after at least two other cancer treatments did not work or have stopped working.
Warnings
Synribo can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, blood in your urine or stools, confusion, problems with vision or speech, or new signs of infection (fever, chills, tiredness, body aches, feeling short of breath).
Before taking this medicine
You should not use Synribo if you are allergic to omacetaxine.
To make sure Synribo is safe for you, tell your doctor if you have ever had:
diabetes (in you or a family member); or
bleeding problems.
Omacetaxine can harm an unborn baby or cause birth defects if the mother or the father is using this medicine.
If you are a woman, do not use Synribo if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.
If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Synribo.
